Capsaicinol is an ingredient of hot red pepper. In this study, we developed a novel method for capsaicinol synthesis and examined capsaicinol's physiological effects on capsaicin receptor (TRPV1)-related actions. Allylic oxidation of capsaicin by palladium acetate (Pd(OAc) 2 ) resulted in the formation of (AE)-capsaicinol acetate at a 7.2% yield in a single step. The effectiveness of (AE)-capsaicinol in TRPV1 activation (EC 50 ¼ 1:1 M) was found to be weaker than that of capsaicin (EC 50 ¼ 0:017 M), whereas the efficacy of (AE)-capsaicinol reached 75% of that of capsaicin. Intravenous administration of (AE)-capsaicinol in anesthetized rats dosedependently enhanced adrenaline secretion from the adrenal gland. The response to a 5 mg/kg-dose of (AE)-capsaicinol was comparable to that of a 0.05 mg/kg-dose of capsaicin. The relative pungency of capsaicinol to capsaicin was coincident with the relative effectiveness in inducing these TRPV1-related actions.
The antioxidant activity of capsaicinol against linoleic acid oxidation is comparable to that of -tocopherol and capsaicin, a well-known pungent ingredient of hot pepper. 1) Capsaicinol is less pungent than capsaicin although its chemical structure is very similar to that of capsaicin ( Fig. 1) .
Capsaicin not only induces a burning sensation, but also elicits various physiological and pharmacological responses. 4, 5) TRPV1, a specific capsaicin receptor and a member of the transient receptor potential vanilloid (TRPV) subfamily, has been cloned and characterized in detail. [6] [7] [8] Activation of TRPV1 is responsible for a majority of capsaicin effects, including the burning sensation. TRPV1 is a non-selective cation channel activated by noxious heat (> 43 C), protons, and vanilloids. Vanilloids are a group of TRPV1 agonists whose structures contain a 4-hydroxy-3-methoxybenzyl moiety. Several naturally occurring and chemically synthesized vanilloids have been reported. [9] [10] [11] [12] [13] Capsaicin stimulates sensory neurons to increase catecholamine secretion via activation of the sympathetic nervous system. 14) An enhancement of energy metabolism due to catecholamine secretion results in thermogenesis, and consequently suppresses adipose tissue deposition. 15, 16) Although capsaicin is an attractive candidate for treating obesity, its strong pungency and harmful stimuli limit its usage as a food additive and in drugs. Several non-pungent capsaicin analogs with longer acyl chains than capsaicin have a potential similar to that of capsaicin for the enhancement of adrenaline secretion in rats 17, 18) and for promoting energy metabolism. 19 ) Previously, we observed that catecholamine secretion in the presence of capsaicin and its analogs was due to the activation of TRPV1 in the sensory neurons. 18) Furthermore, a naturally occurring and non-pungent capsaicin analog, capsiate, increased adrenaline secretion and suppressed body fat accumulation in mice. 20, 21) Capsiate also possessed a TRPV1 activation potential comparable to that of capsaicin. 13) In the present study, we attempted to synthesize capsaicinol by a novel method, viz., allylic oxidation of capsaicin by palladium(II) acetate (Pd(OAc) 2 ). This synthesis was performed prior to physiological assays y To whom correspondence should be addressed. Tel: +81-54-264-5543; Fax: +81-54-264-5550; E-mail: watanbt@u-shizuoka-ken.ac.jp Abbreviations: TRPV1, transient receptor potential vanilloid 1; HEK 293 cells, human embryonic kidney 293 cells; ODV, oil dilution value; SHU, Scoville heat units since capsaicinol could not be obtained in sufficient quantities from natural sources. Next, in order to study whether capsaicinol activates TRPV1, we carried out electrophysiological analysis using the whole cell patch clamp method on recombinant rat TRPV1 that was stably expressed in human embryonic kidney (HEK) 293 cells. Further, we investigated the effect of capsaicinol on adrenaline secretion from the adrenal gland by in situ experiments in anesthetized rats. Finally, we discuss the relationship between the physiological responses, including pungency as evaluated by organoleptic tests, and the lipophilicity of capsaicinol.
Materials and Methods
Chemicals. Capsaicin (> 97% pure), capsazepine (> 99% pure), and the antibiotic G418 were purchased from Sigma (MO, USA). Palladium(II) acetate (Pd(OAc) 2 , > 97% pure) was purchased from Wako Pure Chemical (Osaka, Japan). First-grade reagent capsaicin, containing both capsaicin (60%) and dihydrocapsaicin (40%), was purchased from Wako for the preparation of capsaicinol and its analogs. The other reagents used in this study were of guaranteed grade.
Synthesis of (AE)-capsaicinol by allylic oxidation of capsaicin. The following reagents were added to 200 ml acetic acid solution: 500 mg of first-grade reagent capsaicin (containing 300 mg capsaicin) and 500 mg of Pd(OAc) 2 . The mixture was then agitated at room temperature for 15 h. The reaction products were extracted by the addition of ethyl acetate (250 ml Â 3), and the ethyl acetate solution was washed with water; the products were then dried with Na 2 SO 4 . The residue (780 mg) obtained after evaporation was applied to an MPLC system (Yamazen, Osaka, Japan) under the following conditions: column, Ultrapack SI-40C, 37 mm i.d. Â 300 mm (Yamazen); eluent, a mixture of hexane and ethyl acetate (EtOAc); flow rate, 20-30 ml/ min; detection, UV 280 nm. The hexane/EtOAc (60/40) elution fraction (55 mg) was passed through an alumina column (20 mm i.d. Â 35 mm) with methanol to eliminate highly polar materials. The methanol eluent was chromatographed to afford 1 (9.7 mg, 2.7% isolated yield) and a mixture of 2 and 3 using a preparative HPLC system under the following conditions: column, J'sphere ODS-H80, 20 mm i.d. Â 150 mm (YMC, Kyoto, Japan); eluent, 55% methanol (MeOH); flow rate, 10 ml/min; detection, fluorescence (ex 280 nm, em 320 nm). Compounds 2 (4.2 mg, 1.2% isolated yield) and 3 (4.8 mg, 1.3% isolated yield) were purified from their mixture using an HPLC system under the following conditions: column, Fluofix, 4.6 mm i.d. Â 250 mm (Wako); eluent, 35% MeOH; flow rate, 1.2 ml/min; detection, fluorescence (ex 280 nm, em 320 nm). The 1 H-and 13 C-NMR spectra (TMS as the internal standard) were recorded on a JEOL (Tokyo, Japan) -400 instrument at 399.65 and 100.40 MHz respectively. IR spectra were recorded on a Jasco (Tokyo) FT/IR-550 spectrophotometer, and UV spectra were recorded on a Jasco UVIDEC 660 spectrophotometer. HR-FABMS measurements were carried out on a JEOL JMS-700 spectrometer. A solution of 1 N NaOH was added to the methanol solution of compound 2, and the mixture was maintained at 50
C for 2 h. After neutralization with 1 N HCl, the mixture was treated with EtOAc to afford (AE)-capsaicinol. The spectral data of this synthesized (AE)-capsaicinol were identical to those of the authentic sample. 1) Two enantiomers, (+)-and (À)-capsaicinol, were obtained on repeated HPLC purification from the racemic mixture using a chiral column. The HPLC conditions are described in the legend to Fig. 4 .
Optimization of capsaicinol synthesis. To obtain optimal reaction conditions for (AE)-capsaicinol acetate synthesis, small-scale reactions were performed as follows: To 1 ml of the acetic acid solution of 10 mM capsaicin (> 97% pure), the following were added: 0.1-10 mol fraction of the metal acetates, viz., palladium(II) acetate (Pd(OAc) 2 ), mercury(II) acetate (Hg(OAc) 2 ), lead(IV) acetate (Pb(OAc) 4 ), and manganese(III) acetate (Mn(OAc) 3 ). The reaction mixtures were agitated at 25 C or 70 C. Part of the reaction mixture was then subjected to HPLC analysis to quantify the products and remaining capsaicin. The HPLC conditions are described in the legend to Fig. 2 . Authentic compounds for quantification were prepared using the large-scale reaction described above.
Current recording by whole cell patch clamp method. HEK 293 cells stably expressing rat TRPV1 were obtained as described previously, 22) and were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin, 0.25 mg/ml amphotericin B, and 60 mg/ml G418 under 5% CO 2 at 37 C. The HEK 293 cells with or without TRPV1 expression were spread on glass coverslips coated with poly-Llysine, and were cultured in the culture medium 1-3 d prior to the assay. The glass coverslips with the cells were transferred to a small chamber on the stage of an inverted microscope (IMT2, Olympus, Tokyo). The chamber was perfused continuously with bath solution containing 135 mM NaCl, 2 mM KCl, 2 mM MgSO 4 , 10 mM glucose, 5 mM EGTA, and 10 mM HEPES (pH 7.4). All recordings were performed using standard whole cell patch clamp methods. Glass pipette resistance ranged from 3 to 5 M. The pipette solution contained 140 mM KCl, 5 mM EGTA, and 10 mM HEPES (pH 7.4). The test compound was dissolved in the bath solution containing 0.1% dimethyl sulfoxide. A patch clamp amplifier (CEZ 2300, Nihon Kohden, Tokyo) was used to record the membrane currents. The intracellular voltage was clamped at minus 50 mV. All recordings were made at room temperature. Curve fitting and parameter estimation were carried out using GraphPad Prism 4 (Graph Pad Software, CA, USA).
Measurement of adrenaline secretion in rats. Adrenaline secretion in response to the chemicals was measured from the adrenal vein of anesthetized rats by the use of a continuous blood sampling system, as described previously. 18) Briefly, a rat anesthetized with -chloraloseurethane was placed on a heating pad to maintain the body temperature at approximately 37 C. Two catheters, one each for sample injection and blood sampling, were inserted into the femoral vein and the adrenal vein respectively. Heparinized saline was transfused into the femoral vein during the experiment. Adrenal venous blood was collected after injection of the sample solution (2 vol % ethanol, 10 vol % Tween 80, and 88 vol % saline, volume injected: 1 ml/kg). TRPV1 inhibitor capsazepine was injected 2 min before sample injection. As an internal standard, 3,4-dihydroxybenzylamine was added to the collected blood. After centrifugation, the plasma catecholamines were purified with activated alumina and measured by HPLC-EC. Animal experiment procedures met the guidelines for the care and use of laboratory animals of the University of Shizuoka.
Evaluation of capsaicinol pungency Oil dilution method. The oil dilution method was carried out as described by Watanabe et al., 17) with slight modifications. The test compound was diluted with olive oil to obtain three dilutions that were near to the threshold of pungency predicted by a preliminary test. Twenty microliters of the solution was dropped on the tongues of five trained panels. A linear graph was plotted based on the degree of dilution versus the percentage of panels who felt the pungency. The value of the degree of dilution that corresponded with 50% of the panels who felt the pungency, i.e., the oil dilution value (ODV), was defined as the threshold of pungency for the test compound.
Scoville heat units. Scoville heat units (SHU) of (AE)-capsaicinol were measured using the ISO method. 23) An ethanol solution of (AE)-capsaicinol (5 mg/ml) was diluted with 5% sucrose aqueous solution to obtain five dilutions that were near the threshold of pungency predicted by a preliminary test. Five milliliters of the solution was tasted for 30 s, but not ingested. The SHU of (AE)-capsaicinol was calculated by the same method as the oil dilution values.
These protocols were designed in accordance with the principles of the Declaration of Helsinki of the World Medical Association.
Measurement of capsaicinol lipophilicity. The lipophilicity of (AE)-capsaicinol was evaluated as the partition coefficient according to the n-octanol/water flask shaking method. 24) One milliliter of n-octanol solution of (AE)-capsaicinol (10 mM) was added to 1 ml water in a 5-ml screw vial. The mixture was agitated vigorously at 20 C for 60 min. After centrifugation at 1;600 Â g for 1 min, the (AE)-capsaicinol concentrations of the n-octanol and water fractions were analyzed by the HPLC system, as described previously.
13) The lipophilicity was represented as log P, i.e., the logarithm of the solute concentration of the n-octanol fraction divided by that of the water fraction.
Results and Discussion
Synthesis of (AE)-capsaicinol by palladium acetate oxidation of capsaicin Capsaicinol structurally resembles capsaicin, and they differ only with respect to their side chains. In the case of capsaicinol, an additional hydroxy group is attached at the 7 position. Further, an olefin is located at the 5 position, and not at the 6 position as in capsaicin (Fig. 1) . In brief, rearrangement of the olefin and subsequent hydroxylation at the allylic position convert capsaicin to capsaicinol. The oxidation of olefins by palladium(II) acetate (Pd(OAc) 2 ) yields a variety of products, including allylic acetates with the rearranged olefin.
25) Therefore, we expected that Pd(OAc) 2 might induce capsaicinol production from capsaicin in a few steps.
The allylic oxidation of capsaicin was carried out in a simple manner, i.e., by mixing capsaicin with Pd(OAc) 2 in acetic acid at room temperature. HPLC analysis during the course of the reaction indicated the generation of three main products (1-3) (Fig. 2A) . These compounds were purified by repeated chromatographic separations. The molecular formulae of 1-3 were deduced to be C 20 H 29 NO 5 by high resolution fast atom bombardment mass spectroscopy (HR-FABMS) measurement, and this indicated that C 2 H 2 O 2 had been added to capsaicin. Their 1 H-NMR spectra showed a single peak of three protons at 2.0, and their 13 C-NMR spectra showed a carbonyl carbon of the ester group at 170.5 and a methyl group at 21.3. These data suggested that compounds 1-3 were the acetoxy group adducts of capsaicin.
In the 1 H-NMR spectrum of 1, the two methyl groups at the end of the side chain of 1 shifted by approximately 1 ppm higher field than those in capsaicin, and both the signal patterns were singlets. Furthermore, one of the olefinic carbons ( 137.4) was indicated to be quaternary by DEPT analysis of the 13 C-NMR of 1. Therefore, the olefin in 1 was considered to be at the 7 position. A proton of a methine moiety bound to the acetoxy group was observed to be a double triplet at 5.45. At 9.0 and 6.8 Hz, it coupled with 7-olefinic methine at 5.08 and a 5-methylene group at 1.65 respectively. Based on all these data, the structure of 1 was confirmed to be N-(4-hydroxy-3-methoxybenzyl)-6-acetoxy-8-methyl-7-nonenamide.
In the 1 H-NMR spectrum of 2, a methine proton bound to the acetoxy group was observed to be a triplet at 4.90. At 6.8 Hz, it coupled with an isopropyl methine at 1.7 and an olefinic methine at 5.32, as determined by HH COSY analysis. At 15.6 Hz, the olefinic methine further coupled with another olefinic methine at 5.60. These data indicated the existence of a 7-acetoxy-8-methyl-5E-nonene moiety in 2. The 1 Hand 13 C-NMR spectra of 2 were very similar to those of capsaicinol, except for acetoxy group-related signals. Therefore, the structure of 2 was determined to be N-(4-hydroxy-3-methoxybenzyl)-7-acetoxy-8-methyl-5E-nonenamide, that is, capsaicinol-7-O-acetate. Hydrolysis of 2 by an alkali yielded capsaicinol quantitatively. HPLC analysis revealed that this synthetic capsaicinol was a racemic mixture (Fig. 4A) .
The 1 H-NMR spectrum of 3 revealed a proton of an acetoxy methine at 5.19 and the coupling of two olefinic protons, resulting in trans configuration ( 5.66 and 5.31, 15.6 Hz). Although these signals were similar to those of 2, the acetoxy methine and the olefinic methine at 5.66 were coupled with aliphatic methylene and isopropyl methine respectively. Therefore, the structure of 3 was confirmed to be N-(4-hydroxy-3-methoxybenzyl)-5-acetoxy-8-methyl-6E-nonenamide.
In general, the formation of allylic acetate with simultaneous olefin rearrangement by Pd(OAc) 2 is initiated by the addition of an acetoxy palladium ion ( þ PdOAc) and an acetoxy ion ( À OAc) to olefin; this is followed by the formation of an alternative olefin due to the elimination of HPdOAc. Harris et al. reported that the addition of the two ions to the olefin tends to follow Markovnikov's rule, and that allylic acetate is formed in preference to enol acetate on elimination of HPdOAc. 25) Our results with regards to the formation and ratios of 1 and 2 corresponded with Markovnikov's rule. However, the reaction mechanism for the formation of product 3, which was unexpected, is not clear. The allylic oxidation of capsaicin by Pd(OAc) 2 yielded the 7-O-acetate of (AE)-capsaicinol along with its isomers in a single step. The low isolation yields of these products might be a result of the low reaction yield and loss of product during the purification process.
Optimization of capsaicinol synthesis
To improve the reaction yield of capsaicinol acetate (2), we performed small-scale experiments to optimize the reaction conditions, such as temperature, ratio of starting materials, choice of other metal acetates, and solvents used. The low reaction temperature and low mole fraction of the metal acetate yielded only a trace amount of products. Among several metal acetates, Pd(OAc) 2 and mercury(II) acetate (Hg(OAc) 2 ) yielded products. However, the potential of Hg(OAc) 2 to yield these products was lower than that of Pd(OAc) 2 . No product similar to 1-3 was formed on reacting capsaicin with lead(IV) acetate (Pb(OAc) 4 ) or manganese(III) acetate (Mn(OAc) 3 ), in spite of consumption of capsaicin during the reaction. A higher mole fraction of the metal acetate only increased capsaicin consumption, and no product was formed. These results led to the optimization of conditions as follows: 10 mM capsaicin and an equivalent concentration of Pd(OAc) 2 in acetic acid at 70 C for 20 h or more. Figure 2B shows the time dependency of product (1-3) yields and the remaining capsaicin under these conditions. The capsaicin concentration declined drastically, and the capsaicin was completely consumed before 20 h. On the other hand, the concentrations of 2 and 3 increased gradually, and the yield of 2 reached 7.2% after 20 h. A preference for the formation of 1 was indicated by time course analysis of the products, particularly at the early reaction time (Fig. 2B ), but the long reaction time caused a gradual reduction in yield. This was probably due to further oxidation of 1 by Pd(OAc) 2 .
The rate of production of 1-3 to the consumption of capsaicin did not exceed 25% at any point of time. In the case of simple olefins, metal acetates yield high amounts of the corresponding allylic acetate. [25] [26] [27] The functional groups of capsaicin, such as amide and the phenolic hydroxy group, probably resulted in unsuitable reactions with the metal acetates.
Since capsaicinol cannot be obtained in sufficient quantities from natural sources, the development of a simple method for capsaicinol synthesis is beneficial in study of the biological and physiological activities of capsaicinol. Previous work demonstrated the synthesis of (AE)-capsaicinol from -valerolactone in nine steps, and the overall yield was 18%.
2) In the present paper, we have proposed a novel method of (AE)-capsaicinol synthesis. This method is very useful because it is simple and easy to perform, it is not time consuming, and does not require the use of complicated or expensive devices. The only disadvantage is the low product yield. Further experiments to improve the product yield are in progress.
TRPV1 activation potential of capsaicinol
Capsaicinol belongs to a class of capsaicin analogs that are less pungent. We carried out an electrophysiological analysis to evaluate the effectiveness of capsaicinol in TRPV1 activation using the whole cell patch clamp method. (AE)-Capsaicinol evoked an inward current when the intracellular voltage was clamped at minus 50 mV in TRPV1-expressing HEK 293 cells, while no current was observed in non-transfected cells (Fig. 3A) . The capsaicinol-evoked inward current observed during the perfusion of capsaicinol disappeared immediately after the capsaicinol was washed out; this decline of capsaicin-evoked current was gradual. The response of (AE)-capsaicinol increased dose-dependently, and the EC 50 and the Hill slope were 1.1 mM and 1.8 respectively (Fig. 3B) . The potency of (AE)-capsaicinol was 60 times weaker than that of capsaicin (EC 50 ¼ 0:017 mM, Hill slope = 1.3). Maximum current was recorded when the concentration of (AE)-capsaicinol was 10 mM (minus 1:25 nA AE 0:48, mean AE S.D., n ¼ 6), and the value obtained was approximately 75% of that obtained with 1 mM capsaicin (minus 1:66 nA AE 0:34, n ¼ 6). The currents caused by 10 mM (AE)-capsaicinol were completely eliminated by simultaneous perfusion with 20 mM capsazepine, a competitive TRPV1 antagonist (Fig. 3C, D) . The capsaicin-evoked inward current was also significantly attenuated by capsazepine.
Capsaicinol has an asymmetric carbon at its 7 position (Fig. 1) . The absolute configuration of the 7 position of naturally occurring capsaicinol is R, and its optical rotation has a negative value, 3) i.e., (À)-capsaicinol. Analysis of chemically prepared capsaicinol by an HPLC system equipped with a chiral column showed two peaks of the same area (Fig. 4A) . Therefore, the chemically prepared capsaicinol was probably a racemic mixture, (AE)-capsaicinol; this was confirmed by optical resolution analysis. There was no difference in TRPV1 activation potency between the enantiomers and the racemic mixture of capsaicinol (Fig. 4B) .
Here, we demonstrated that capsaicinol possesses the ability to activate TRPV1. Although the potency of capsaicinol was lower than that of capsaicin or capsiate, 13) its potency was comparable with other natural vanilloids such as gingerol (EC 50 ¼ 0:56 mM), zingerone (EC 50 ¼ 74 mM), and eugenol (EC 50 % 1 mM). 9, 10) It is well-known that the length of the acyl moiety in vanilloids is important for TRPV1-related effects such as pungency, antinociception, and antiinflammation, 28, 29) but except for one report, the effect of the substitution of a hydroxy group in the acyl moiety of capsaicin has not been reported. Only one case has demonstrated that the efficacy of TRPV1 activity was increased without greatly altering potency when a hydroxyl group was substituted in the longer acyl moiety (C 18:1 ) of vanilloid.
12) The vanilloid-binding site of TRPV1 has been determined by means of the gene engineering technique. 30, 31) The recognition site of the vanillyl moiety in vanilloids is located in the N-and C-terminal cytosolic tails of the TRPV1 membrane protein. On the other hand, the acyl moietybinding site located in the transmembrane region of TRPV1 requires the acyl moiety to have a specific hydrophobicity. Therefore, the decrease in hydrophobicity due to the hydroxylation of the acyl moiety in capsaicin (viz., capsaicinol) probably reduces its affinity to TRPV1. Furthermore, recognition of the side chain of vanilloids by TRPV1 might be loose because there are various TRPV1 activators that possess diverse side chains. This loose recognition might explain the equal effectiveness of TRPV1 activation by the enantiomers of capsaicinol.
Enhancement of adrenaline secretion in rats
Enhancement of catecholamine secretion prompts the activation of energy metabolism in mammals. We reported previously that adrenaline secretion in rats was a result of TRPV1 activation by intravenously injected capsaicin.
18) Hence, we investigated whether the TRPV1 activator (AE)-capsaicinol induces adrenaline secretion in rats. Figure 5A shows the time course of adrenaline secretion in anesthetized rats intravenously injected with (AE)-capsaicinol. A dose of over 2.5 mg/kg (8.0 mmol/kg body weight) (AE)-capsaicinol enhanced adrenaline secretion immediately after injection. Once secretion declined to half the initial response, it gradually increased again. In brief, (AE)-capsaicinol showed a two-phase pattern of adrenaline secretion, i.e., rapid and transient increases and slow and prolonged increases. These responses increased dose-dependently. The initial response elicited by a dose of 5.0 mg/kg (AE)-capsaicinol was comparable to that of a 0.05 mg/kg dose of capsaicin. On the other hand, the later response even when a dose of 2.5 mg/kg (AE)-capsaicinol was injected tended to be greater than when a dose of 0.05 mg/kg capsaicin was injected. The total amount of adrenaline secretion over 18 min caused by 0 (vehicle), 0.5, 2.5, and 5.0 mg/kg (AE)-capsaicinol, and a 0.05 mg/kg dose of capsaicin, was 240, 270, 1,150, 1,640, and 1,190 ng/kg respectively. Coinjection of a dose of 20 mg/kg capsazepine significantly attenuated the response to a 2.5 mg/kg dose of (AE)-capsaicinol (Fig. 5B) .
Previously, we found that some vanilloids such as capsaicin, olvanil, and resiniferatoxin caused adrenaline secretion in rats. 18) There were two time-dependent patterns of secretion: a capsaicin-like two-phase pattern and an olvanil-like one-phase pattern. The response to capsaicinol showed the former pattern. This is probably because capsaicinol is structurally similar to capsaicin rather than to olvanil. Kawada et al. reported that the biological half-life of intraperitoneally injected capsaicin in blood was approximately 7 min in rats. 32) Intravenously injected capsaicin was reduced by half at 4 min (Watanabe et al., unpublished data). Therefore, the first phase of adrenaline secretion, up to 9 min caused by capsaicin and capsaicinol probably depends on their concentrations in the blood. The maximum secretion observed immediately after injection of capsaicin was saturated at a dose of 0.1 mg/kg. 18) The maximum secretion induced by a dose of 5 mg/kg capsaicinol was equivalent to that induced by 0.05 mg/kg of capsaicin, which was half of the saturated secretion induced by capsaicin. On the other hand, the total amount of adrenaline secretion induced by 0.05 mg/kg of capsaicin was comparable to that induced by 2.5 mg/kg of capsaicinol. Therefore, the effectiveness of capsaicinol in inducing adrenaline secretion was approximately 50-100 times lower than that of capsaicin. The relationship between the potencies of capsaicinol and capsaicin coincided with that of the above-mentioned TRPV1 activation potencies. The agreement of physiological responses in the whole body and at the molecular level is probably due to similar physicochemical properties based on the structural resemblance between the two compounds.
The relationship between the physiological activities and lipophilicity of capsaicinol
We have described the effects of capsaicinol on TRPV1 and adrenaline secretion in the present paper. Additionally, we evaluated the pungency of capsaicinol as one of the TRPV1-related responses. Table 1 shows the pungency thresholds of capsaicinol and capsaicin evaluated by two methods. The results from both methods indicated that the pungency of capsaicinol was approximately 100-fold weaker than that of capsaicin. On the other hand, we measured the lipophilicity, log P, of the two compounds as one of the physicochemical characters by the n-octanol/water flask shaking method. 24) As Table 1 shows, the lipophilicity of capsaicinol is lower than that of capsaicin, which is in agreement with our expectations.
To show physiological activity, a ligand must gain access to its receptor across certain ''barriers'' such as the mucosa, lyase enzyme, its own stability, and so on.
In other words, the potency of a ligand depends not only on its affinity but also on the accessibility to its receptor. Thus the physicochemical properties of ligands, such as lipophilicity and stability, are important in understanding the response. Extremely low or high lipophilicity reduces pungency even if the ligand possesses a high affinity for TRPV1. For example, olvanil, a capsaicin analog having a longer acyl chain, possesses greater TRPV1 activation potency than capsaicin, in spite of its non-pungency. 13) It is believed that the extremely high lipophilicity (log P ¼ 9:12) of olvanil hardly allows it access to TRPV1 in the tongue because TRPV1 is covered with the epitheliocyte in the tongue. 33) Capsiate, which has a higher lipophilicity (log P ¼ 5:80) than capsaicin, is also non-pungent. 13) In case of capsiate, its lipophilicity and instability probably contribute to its organoleptic properties. 34) In contrast to olvanil and capsiate, the lipophilicity of capsaicinol is lower than that of capsaicin, but the accessibility of capsaicinol to TRPV1 in the tongue might not differ greatly from that of capsaicin because capsaicinol can still be considered lipophilic (log P > 1). Considering that the accessibility and stability of capsaicinol are identical to those of capsaicin, it is not surprising that the relative pungency of capsaicinol to capsaicin is consistent with the relative TRPV1 activation potency of capsaicinol to capsaicin. The same phenomenon probably explains the relationship between TRPV1 activation potency and the adrenaline secretion induced by the two compounds. 
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Ã The SHU of capsaicin is quoted from the literature. 35) 
